Pfizer Inc.
- PFE
- NYSE
- Drug manufacturers
- Branded Pharmaceuticals
- Vaccines
$29.44
Today −0.47%Quote Oct 19, 2026, 08:01 PM UTC
+6.44%over the last month
Max drawdown −4.6%From 1-month high −0.5%3 months +18.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Pfizer
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis.
Where the money comes from
Q2 2026 revenue $15.03B
- Biopharma Segment$14.66B97.5%
- Segment Reporting, Reconciling Item, Corporate Nonsegment$373.0M2.5%
Sector
Healthcare
Industry
Drug manufacturers
Exchange
NYSE
Employees
75,000
Dividend date
Dec 7, 2026
Market value
$167.80B
Quote Oct 19
Floor
$29.20
0.8% below price
Resistance
$29.64
0.7% above price
Price vs analyst targets
40 analysts
Lowest target
$26.00Highest target
$33.00
$26.00Highest target
$33.00
- Price $29.44
- Average target $29.17
- Analysts' target range
Analysts' average target sits about 1% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PFEPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free